drugset / Trial / NCT01585038
Efavirenz Versus Rilpivirine on Vascular Function, Inflammation, and Oxidative Stress
RandomizedParallel-groupSingle-blindTreatment
Summary
The purpose of this study is to compare the cardiovascular profiles of efavirenz and rilpivirine, which are two drugs used to treat HIV infection.
Timeline
- Start
- 2012-07
- Primary completion
- 2014-05
- Completion
- 2014-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Efavirenz | Other / unclassified | 600 mg | Oral |
| Comparator | Rilpivirine | Small molecule | 25 mg | Oral |